MBX vs ZBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 20, 2026

MBX

46.3
AI Score
VS
ZBIO Wins

ZBIO

60.4
AI Score

Investment Advisor Scores

MBX

46score
Recommendation
HOLD

ZBIO

60score
Recommendation
BUY

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric MBX ZBIO Winner
Net Income -377.74M -60.61M MBX
Operating Income -383.06M -68.20M MBX
ROE -156.0% -14.8% MBX
ROA -98.5% -13.9% MBX
Total Assets 383.64M 435.91M MBX
Cash 110.64M 54.12M ZBIO
Current Ratio 5.61 18.08 MBX
Free Cash Flow -172.35M -44.17M MBX

Relative Price Performance (Last 90 Days)

MBX 1M: +4.3% · 3M: +108.7% ZBIO 1M: +4.2% · 3M: +62.8%

Current Technical Phase

MBX

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (31.0% over 20 days), RSI 55

RSI (14): 55.3 · Price: $66.33

ZBIO

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (23.2% over 20 days), RSI 59

RSI (14): 58.5 · Price: $32.29

Fundamentals Snapshot

Metric MBX ZBIO
Market Cap
Forward P/E -16.8 -6.7
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% -1.0%
Gross Margin -212.5%
Operating Margin 0.0% -77.7%
EPS -2.30 -9.63
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, ZBIO is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.